Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for PAVM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Research and Development Expense (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 6.352M
March 31, 2026 5.094M
December 31, 2025 4.493M
September 30, 2025 3.472M
June 30, 2025 3.926M
March 31, 2025 4.777M
December 31, 2024 5.931M
September 30, 2024 8.719M
June 30, 2024 10.34M
March 31, 2024 12.17M
December 31, 2023 14.66M
September 30, 2023 17.74M
June 30, 2023 20.78M
March 31, 2023 24.06M
December 31, 2022 25.55M
September 30, 2022 25.84M
June 30, 2022 24.95M
March 31, 2022 22.46M
December 31, 2021 19.85M
September 30, 2021 16.52M
June 30, 2021 13.83M
March 31, 2021 11.71M
Date Value
December 31, 2020 11.02M
September 30, 2020 9.635M
June 30, 2020 8.535M
March 31, 2020 7.807M
December 31, 2019 6.630M
September 30, 2019 5.746M
June 30, 2019 5.398M
March 31, 2019 5.141M
December 31, 2018 4.253M
September 30, 2018 3.438M
June 30, 2018 2.971M
March 31, 2018 2.525M
December 31, 2017 2.619M
September 30, 2017 2.670M
June 30, 2017 2.544M
March 31, 2017 2.197M
December 31, 2016 1.720M
September 30, 2016 1.254M
June 30, 2016 0.94M
March 31, 2016 0.6525M
December 31, 2015 0.4893M

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Abbott Laboratories 3.128B
AngioDynamics, Inc. 29.45M
Alphatec Holdings, Inc. 76.69M
AtriCure, Inc. 94.05M
Baxter International, Inc. 480.00M